Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SPRY compared with PRLD: revenue, margins and what each company keeps, and the suppliers and customers both name
SPRY
ARS Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
PRLD
Prelude Therapeutics Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
SPRY
ARS Pharmaceuticals, Inc.
vs
PRLD
Prelude Therapeutics Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
SPRY
ARS Pharmaceuticals, Inc.
Change
3.37
▼
−8.06%
· post 3.37
Mkt cap
$336.1M
Revenue
$34M
Q2 FY26
Revenue
$84M
FY25
PRLD
Prelude Therapeutics Inc
Change
3.89
▼
−5.01%
· post 3.89
Closed
Oct 30 '26
Mkt cap
$309.6M
Revenue
$6M
Q2 FY26
Revenue
—
vs
Compare
Closed
Oct 30 '26
SPRY
ARS Pharmaceuticals, Inc.
vs
PRLD
Prelude Therapeutics Inc
3.37
▼
−8.06%
post 3.37
Price
3.89
▼
−5.01%
post 3.89
$336.1M
Mkt cap
$309.6M
Q2 FY26
$34M
Revenue
$6M
Q2 FY26
FY25
$84M
Revenue
—
Change
Change
SPRY
3.37
▼
−8.06%
vs
PRLD
3.89
▼
−5.01%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SPRY, solid
PRLD, dashed
Supply-chain overlap
Revenue flow
SPRY: latest quarter is a loss; flow not drawable. PRLD: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only SPRY
18
—
ALK
unlisted
supplier
—
ALK U.S
unlisted
supplier
—
Recordati Ireland
unlisted
supplier
—
Aegis Therapeutics
unlisted
supplier
14 more · SPRY chain
›
Shared
0
No shared counterparties.
Only PRLD
3
INCY
Incyte
customer
ABCL
AbCellera Biologics
customer
—
Pathos AI
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR